Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Finder Agreement

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Finder Agreement

Entities:

DOR BioPharma, Inc.; Endorex Corporation; DOR Biopharma Inc.

Date:

2000

Size:

Preview shows 2KB of 21KB total

Price:

$36

ID:

#116244

 

 

► Fee Agreements ► Finders Agreements
► Biotech & Drugs ► Pharmaceutical Preparations

 

 

Start of Preview




February 29, 2000



Mr. Michael S. Rosen
President and Chief Executive Officer
Endorex Corporation
28101 Ballard Drive, Suite F
Lake Forest, IL 60045

Finder Agreement
----------------

Dear Sirs:

Reference is made to our recent discussions relating to a proposed private
placement under Rule 506 of Regulation D of the Securities Act of 1933, as
amended (the "Act") of securities of Endorex Corporation (the "Company") as
hereinafter described. Based upon our discussions and representations which you
have made to us describing the Company and its principals, the present and
proposed business activities of the Company and the Company's operations and
financial condition, Paramount Capital, Inc. ("Paramount") hereby confirms in
principle its interest in acting as a finder for the Company, on a "best
efforts" basis, in connection with the private placement offering of the
Company's Units (the "Offering"), upon the following basic terms and conditions:

1. Paramount will introduce the Company to "accredited investors" as
defined in Rule 501 of Regulation D promulgated under the Act for the purchase
of Units. Each "Unit" shall consist of (i) a number of shares of common stock of
the Company (rounded to the nearest whole share, with one-half (0.5) of one
share, or greater fraction thereof, being rounded upward), par value $.001 per
share (the "Common Stock"), determined by dividing one hundred thousand dollars
($100,000) by the lower of (a) the average closing price of the Common Stock, as
quoted on the American Stock Exchange, for the five (5) consecutive trading days

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC